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 We must all hang together, or most assuredly 
we shall all hang separately.
Benjamin Franklin, July 1776
our times are difficult, but not as difficult as those of the pre-Revolutionary patri-ots of the American colonies. As they 
sought to create a new country based on lofty 
but untested principles, against the wishes of 
many of their friends and neighbors, they risked 
ostracism and worse. They were a minority with-
in the general population, working to convince 
and inspire others who did not already embrace 
their passion.
Although the stakes may not be as high, one 
could argue that the community represented by 
JID is similarly struggling to frame the critical 
issues of our day and to rally needed support to 
the cause of investigative dermatology. Like those 
determined to create a better society in the New 
World more than two centuries ago, the investi-
gative dermatology community needs the support 
of a relevant majority, composed of groups whose 
future will assuredly be affected by our success 
or failure but whose day-to-day preoccupations 
often eclipse this truth. Such groups include prac-
ticing dermatologists, the pharma ceutical and 
device industries, and patient advocates. Without 
a united front that includes the leadership of 
these diverse stakeholders in skin research, 
investigative dermatologists and cutaneous 
biologists are at risk of failing to achieve our high-
est goals. In a world of competing priorities and 
constrained resources, failure to articulate our 
vision may well result in fragmentation of effort 
and loss of needed synergies among like-minded 
constituencies with somewhat different perspec-
tives and short-term goals.
Today, the enterprise of investigative der-
matology and cutaneous biology competes 
financially and otherwise with concerns for 
health-care costs and disparities, other research 
agendas, the day-to-day demands of patient 
care, and differing individual priorities and 
societal goals. Here and in guest editorials 
throughout the year, we will argue that support-
ing the work reflected in JID’s original reports is 
critical to the success of all our constituencies 
(Figure 1). Equally, interpreting these advances to 
those responsible for patient care and physician 
training, as well as to the intended beneficiaries 
of these advances—those with diseases of the 
skin, our patients—lies solidly within JID’s man-
date. Finally, as behooves a journal with parent 
societies in both Europe and the United States, 
as well as subscribers and contributing authors 
around the world, we will demonstrate that 
international collaborations for research train-
ing, and for research itself, are of paramount 
importance in our global community.
the vision and the goal
My vision is fivefold: (i) to publish excellent sci-
ence that advances our understanding of normal 
and diseased skin; (ii) to provide authoritative 
interpretive summaries that make these scientific 
advances accessible and relevant to the wider 
scientific community, including dermatology 
trainees and clinician–educators; (iii) to sup-
port communities of investigative dermatologists 
and cutaneous biologists by publishing meeting 
abstracts and meeting reports; (iv) to introduce 
the next generation of scientists and educators 
to the activities that are critical to our continued 
progress; and (v) to employ appropriate technol-
ogies to accomplish this vision.
Overall, the vision is of a single unified com-
munity, with the specific goals of each subgroup 
supported by the whole, to the benefit of all. I 
see these goals as interrelated: (i) enhancing our 
ability to prevent and treat skin disease through 
new knowledge; (ii) strengthening the investiga-
tive community responsible for these advances; 
(iii) communicating the relevance of research 
discoveries to the larger medical and scientific 
communities; and (iv) achieving optimal inter-
actions among investigators, trainees, and other 
stakeholders worldwide.
Jid’s stakeholders
Investigators and clinicians. It is possible to 
see investigators and clinicians as being worlds 
apart, differing in education and training, work 
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environments, reward systems, and day-to-day concerns. 
However, their ultimate goals are the same: improved human 
health. Without astute clinicians, skin disease would remain an 
undifferentiated misery. Without their curiosity and caring, the 
clues to disease pathogenesis inherent in therapeutic responses 
and failures would not inform the research process, and hard-
won, laboratory-derived knowledge would never benefit 
patients. Conversely, without laboratory-based and clinical 
investigators, therapeutic advances would rely on serendipity 
alone, a most inefficient approach. Dermatology would increas-
ingly be seen as trivial and empirical. Without good commun-
ication and mutual respect between these two seemingly polar 
groups, advances in dermatologic care would slow.
Mutual support is equally critical; this includes financial 
support of relatively poorly funded investigators—particularly 
at critical times early in their careers—by clinical societies 
and individual clinicians through organizations such as the 
Dermatology Foundation. It also includes the donation of 
time and effort by investigators to participate in the basic-
science education of dermatology residents and practicing 
dermatologists through lectures and seminars at their own 
institutions and at regional, national, and international meet-
ings, as well as through preparation of textbook chapters and 
journal-based review articles, commentaries, and editorials. 
Such activities are time-consuming, unpaid, and difficult, but 
they are essential to keeping the clinical side of our specialty 
informed about and committed to its science base.
Research trainees and their mentors. Laboratory-based grad-
uate students and postdoctoral fellows face a daunting task. 
In a few short years, they are required to master a wide array 
of sophisticated techniques and (often) modify them to best 
suit their specific projects, while simultaneously digesting a 
dense literature in order to choose—and later to advance—a 
rather narrow field within a field. Much rides on each of their 
decisions. Failure to answer the initially chosen question(s) in 
a satisfactory manner may greatly extend their period of train-
ing and may permanently alter their career trajectories. They 
must publish—and in the right places—or perish. They must 
compete successfully for recognition (and often for funding) 
while still neophytes in their field. Almost no one can navi-
gate this critical period without good advice and emotional 
support. In most cases, the source of this nurture is the labo-
ratory mentor, who is in most cases the laboratory supervisor.
Organizations such as the Society for Investigative 
Dermatology (SID) and the European Society for Dermatologic 
Research (ESDR) play key roles in introducing trainees to 
other trainees and to senior investigators, fostering cross-
fertilization and setting standards by example. The SID, the 
ESDR, and similar groups ensure that would-be mentors 
understand the importance of their expected role vis-à-vis 
trainees. Other organizations celebrate outstanding men-
tors in order to publicly reinforce this message: notably, the 
American Skin Association through its David Martin Carter 
Mentor of the Year Award and JID itself through its Year of the 
Mentor theme in 2011 (Bergstresser, 2011).
Of course, mentors need trainees, not only to work 
doggedly on laboratory projects of mutual interest but also 
to provide enthusiasm and a “beginner’s mind” for difficult 
challenges. For many senior investigators, the achievements 
of the trainees themselves are as much the fruit of their labor 
as the laboratory findings that result from their joint efforts.
JID publishes findings from many doctoral theses and 
other papers critical to the future of trainees in dermatolog-
ic investigation. Through its recent initiatives, introduced as 
part of the concept of the JID Connector, we also hope to 
engage clinical trainees through journal-based learning and 
information exchange with both peers and potential mentors.
Patient advocates. The field of dermatology, including JID, 
has a long history of working with patient-advocacy groups. 
Several of the disease-specific organizations raise and distrib-
ute money to support research in their area(s) of interest, and 
almost all receive guidance and strong support from their 
medical/scientific advisory boards. By lobbying Congress for 
research funding, the US-based Patient Coalition, as well as 
individual patient-advocacy groups, ensure that our strongest 
investigators receive federal grants and ultimately publish 
their work in journals such as JID. These investigators sup-
port the Journal as subscribers, submitting authors, and edi-
torial board members and—primarily—pursue answers to 
the problems confronting dermatology patients. Without the 
patient-advocacy groups, individual investigators would have 
a far more restricted acquaintance with the diseases they 
seek to impact, and recruitment for clinical trials, particularly 
for rare diseases, would be far more difficult.
Translational researchers and drug/device developers. 
As committed as many investigators are to the concept 
of bench-to-bedside research, very few have either the 
knowledge or the resources to accomplish this translation. 
Similarly, major pharmaceutical companies, entrepreneurs, 
and venture capitalists are often unaware of new biologic 
targets or other research findings that might spur develop-
ment of new therapeutics. Despite appropriate concern for 
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Figure 1. Components of the complex “skin world.” The dermatologic 
research community, here identified with JID, is intimately connected to all the 
other components. The strength of the relationships among the groups varies 
markedly, depending on the particular individuals or organizations under 
consideration, and it also varies over time. In general, however, the relationship 
between clinical trainees and clinicians, particularly those responsible for their 
training, is especially close, as indicated by the double link.
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the management of conflicts of interest, better communica-
tion between the research and development communities 
is desperately needed. Too many powerful discoveries 
languish in university laboratories or are commercially 
compromised by failure to protect the inherent intellectual 
property. Companies eager to fill their pipelines with drug 
candidates or device prototypes often have limited or no 
access to the potential sources. Ethical means of bridging 
this divide must be a high priority of all committed to 
improving patients’ lives.
the importance of cultural contexts
Traditionally, countries have differed in their racial and 
ethnic characteristics, burden of disease, disease profile, 
health-care economics, and national agendas. In recent 
decades, these differences have diminished as the result 
of geographic mobility, globalization of the economy, and 
frequent individual travel, with its associated risks of disease 
exposure and transmission. However, attitudes toward deliv-
ery of health care, specific therapies, funding of medical 
research, teaching/learning strategies, and the academic 
enterprise itself evolve slowly. Thus, it behooves one who 
aspires to a research career in the twenty-first century to be 
fully aware of the differences among the investigative com-
munities around the globe.
In a world of international meetings and research 
consortia, travel fellowships, foreign sabbaticals, and far-flung 
postdoctoral training opportunities, investigators or trainees 
who do not sample this intellectual smorgasbord limit 
both their own horizons and their potential contributions. 
Research leaders around the world have an obligation to the 
future of their specialty to encourage such cross-fertilization 
at all levels. Happily, the SID, the ESDR, the Japanese 
SID, and many other region-based societies have already 
instituted invited lectures for established investigators and 
travel fellowships for trainees at their national meetings, and 
numerous other exchange mechanisms are being explored. 
Service on international editorial boards and grant-review 
committees offers other means of promoting common 
standards and best practices worldwide.
Conclusions
Every day brings better understanding of normal and diseased 
skin, and therapeutic advances continue at a staggering rate. 
The ongoing scientific revolution promises an even brighter 
future. To truly realize this promise, however, all stake-
holders must work together to achieve our ultimate goal of 
improved skin health for all. We must hang together. JID 
stands ready to participate and, where possible, to unify and 
synergize our efforts.
Barbara A. Gilchrest
Editor
REFERENCE
Bergstresser, PR (2011) 2011: The Year of the Mentor. J Invest Dermatol 131:1
